Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 14, 2024 12:30pm
RE:RE:On the bright side
I would rather see Sirona take 51% of future sales of $100M than 90% of nothing. If Sirona had a buyout clause that would assert its full ownership rights down the road after everything was paid back
...more
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 14, 2024 8:41am
RE:RE:On the bright side
As long as it isn't 5 bucks!
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Mar 14, 2024 7:55am
RE:On the bright side
Next news: PE Partner buys 49% of sirona laboratories for 5 mio$
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Mar 13, 2024 5:16pm
On the bright side
If, by chance, AbbVie starts promoting a 1067 product at the same time, early next year, when GlycoProtemim hits the market, it could get interesting. It will likely be a painful 2024 for SBM's
...more
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 13, 2024 3:50pm
RE:RE:RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
You will note that I hadn't responded to your drivel for quite some time, as I did have you on ignore. I took you off today just to see if anything has changed, and no, it hasn't. All you post
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 13, 2024 2:14pm
RE:RE:RE:They have a real product to compete with BOTOX!
Finally Sirona may actually be in sync and part of a solution with a broader movement.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 13, 2024 2:11pm
RE:RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
1067 my good buddy is licensed globally and with an organization far more competent and resources than Sirona to bring to market. Like I said, if one believes that Allergan will get to market, then 8
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Mar 13, 2024 1:51pm
RE:RE:They have a real product to compete with BOTOX!
Botox also gives immediate side effects. One of most successful influencers had to stop using because of ruined smile. Follow the breadcrumbs and you will soon find out that the world of beauty is
...more
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 13, 2024 1:12pm
RE:RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
More pointless word salad. What about 1067 that you pumped endlessly?
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Mar 13, 2024 1:06pm
RE:RE:New Press Release - Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
You can't lay a golden egg until you have a chicken. The fact that they will have a production ready product they can table drop in front of a stakeholder is MASSIVE. Speculation happens
...more
(9)
•••
Engcan77
X
View Profile
View Bullboard History
Comment by
Engcan77
on Mar 13, 2024 12:34pm
RE:RE:They have a real product to compete with BOTOX!
I guess it also depends if you prefer needles in the face and a fake look, or a more subtle way of implementing a product with a more natural look :)
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Mar 13, 2024 12:28pm
Someone bought 49,000 shares at 8 cents
Was that you bioruns? No, I didn't think so. But without something on the Abbvie deal, the share price probably won't go anywhere until GlycoProteMim hits the shelves, which is a ways off
...more
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 13, 2024 11:25am
RE:They have a real product to compete with BOTOX!
Botox gives immediate results, 1326 works after months of daily applications.
(2113)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Mar 13, 2024 11:23am
RE:RE:Why no Allergan product?
" Howie over-emphasized statements " That is putting it mildly.
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income